Evidence map›Paper›PMID 33123228›Full record

ReviewExperimental and therapeutic medicine2020

Treatment trends in oral lichen planus and oral lichenoid lesions (Review).

Doina Rotaru, Radu Chisnoiu, Alina Monica Picos, Andrei Picos, Andrea Chisnoiu

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07131813 (Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus), which is not on this map. Cited by 40 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 5 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07131813 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus: A Randomized Clinical Trial

TypeinterventionalSponsorAll India Institute of Medical Sciences, BhubaneswarRan2025 to 2027Enrolled60ConditionsOral Lichen PlanusArmsTofacitinib 5 mg BID and Triamcinolone ointment, Placebo and Triamcinolone ointment
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 5 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Doina RotaruDepartment of Odontology, Endodontics and Oral Pathology, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400001 Cluj-Napoca, Romania.
Radu ChisnoiuDepartment of Odontology, Endodontics and Oral Pathology, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400001 Cluj-Napoca, Romania.
Alina Monica PicosDepartment of Prosthodontics, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
Andrei PicosDepartment of Prevention in Dental Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400089 Cluj-Napoca, Romania.
Andrea ChisnoiuDepartment of Prosthodontics, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
Iuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral lichen planus (OLP) is a chronic inflammatory disease, associated with altered cell-mediated immunological function. It has long-term evolution, repeated exacerbations, sometimes painful and resistant to treatment, even all of these, OLP significantly affects patient's life quality. Not least, OLP is accompanied by an increased risk of malignant transformation. A wide spectrum of therapeutic options is available, but none are curative. In this review, 58 structured studies on the clinical symptomatology and treatment strategy of OLP were analyzed. The literature research was performed according to the criteria of the PRISMA system. This study summarizes current knowledge regarding management of OLP and oral lichenoid lesions, discusses the challenges of choosing an adequate treatment and, in attempt to improve the quality of patient life, trying to describe a therapeutic algorithm that takes into consideration the clinical features of the disease. Current OLP therapy aims at eliminating all mucosal-related lesions, reduce symptomatology and decrease the risk of oral cancer and include corticosteroids, immunomodulatory agents, retinoids, ultraviolet irradiation and/or laser therapy.

Indexed as

immunitymanagementoral lichenoid lesionsoral lichen planustherapeutic algorithmtreatment

Identifiers

PMID33123228
PMCPMC7588785
OpenAlexW3094365095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.